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Abstract
Background—How the longitudinal asthma control status and other socio-demographic factors 
influence the changes of health-related quality of life (HRQOL) among asthmatic children, 
especially from low-income families, has not been fully investigated.
Objectives—This study aimed to describe the trajectories of asthma-specific HRQOL over 15 
months, and examine the effect of asthma control status on HRQOL by taking socio-demographic 
factors into consideration.
Methods—229 dyads of asthmatic children and their parents enrolled in public insurance 
programs were recruited for assessing asthma control status and HRQOL over 4 time points of 
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assessment. Asthma control status was measured using the Asthma Control and Communication 
Instrument and asthma-specific HRQOL was assessed using the Patient-Reported Outcomes 
Measurement Information System’s Pediatric Asthma Impact Scale. Latent growth models 
(LGMs) were applied to examine the trajectory of HRQOL and the factors contributing to the 
changes of HRQOL.
Results—Unconditional LGM revealed that HRQOL was improved over time. Conditional LGM 
suggested that accounting for asthma control and participants’ socio-demographic factors, the 
variation in the initial level of HRQOL was significant, yet the rate of change was not. Conditional 
LGM also revealed that poorly-controlled asthma status was associated with poor HRQOL at each 
time point (p’s<0.05). Lower parental education was associated with lower baseline HRQOL 
(p<0.05). Hispanic children had a larger increase in HRQOL over time (p<0.01) than non-
Hispanic White children.
Conclusions—Vulnerable socio-demographic characteristics and poorly controlled asthma 
status affect HRQOL in children. This finding encourages interventions to improve asthma control 
status and HRQOL in minority children.
Keywords
Asthma control; children; health-related quality of life; patient-reported outcomes; latent growth 
models
INTRODUCTION
Approximately 7 million (9%) American children and adolescents had asthma in 2012 (1). 
The National Asthma Education and Prevention Program’s Expert Panel Report-3 (NAEPP 
EPR-3) guideline provides a clear definition for asthma control and underscores the 
importance of achieving adequate asthma control as the goal of asthma management (2). The 
Asthma Outcomes Workshop, sponsored by the National Institutes of Health and the Agency 
for Healthcare Research and Quality, emphasizes the significance of improving asthma 
control for optimizing health-related quality of life (HRQOL) of asthmatic individuals (3).
The relationship between asthma control and HRQOL is complex. Although numerous 
studies reported the association between poorly-controlled asthma status and impaired 
HRQOL, these studies are largely based on cross-sectional designs (4, 5). Sparse 
longitudinal studies are available to elucidate the progression of asthma in children and 
adolescents, especially the associations between the changes in asthma control status and the 
changes in HRQOL.
Several risk factors (e.g., low levels on physical activity (6), self-efficacy (6), and health 
literacy (7)) might contribute to the changes of asthma control status and HRQOL. The 
changes in clinical parameters (forced expiratory volume in one second (8)) were also shown 
a significant association with the variations in HRQOL. In pediatric asthma, child, parental, 
and family factors including older age (9–11), low-income family (12, 13), ethnic minority 
group (14, 15), and low maternal educational attainment (12, 16) determined asthma control 
status and HRQOL.
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The present study aimed to examine the change of HRQOL over a 15-month study period, 
and to identity important factors determining the changes of HRQOL. A group of asthmatic 
children between 8 and 17.9 years of ages engaged in this study, and HRQOL was measured 
using the Patient-Reported Outcomes Measurement Information System (PROMIS®) 
Pediatric Asthma Impact Scale (17). Given that HRQOL assessed by legacy measures (e.g., 
the Mini-Asthma Quality of Life Questionnaire (7) and the EQ-5D (18)) was improved over 
time in previous prospective, observational cohorts, we hypothesized that HRQOL in 
asthmatic children would increase overall during the study period. However, individuals 
whose asthma status was poorly-controlled would experience impaired HRQOL at 
individual time points of assessment. Socio-demographic factors including children’s race/
ethnicity, comorbidities with other chronic conditions, and parental education were 
hypothesized to explain the initial status and the rate of changes in HRQOL.
METHODS
Participants and Data Collection
This study used data collected from the PROMIS Pediatric Asthma Study that was primarily 
designed to test responsiveness and minimally important differences (MIDs) for the 
PROMIS Pediatric measures. After the University of Florida’s institutional review board 
approved the protocol, a total of 229 dyads of asthmatic children and their parents were 
recruited from Florida Medicaid and the State Children’s Health Insurance Program 
(SCHIP). Inclusion criteria for study participation were: age between 8 and 17.9 years for 
children and 18 years or older for parents; continuous enrollment (≥ 6 months) in Florida 
Medicaid and SCHIP; asthma diagnosis (ICD-9-CM: 493.1, 493.2 or other 493.x) listed in 
Florida Medicaid and SCHIP claims/enrollment files; at least two asthma-related health care 
visits during the past year; and family accessibility to internet and telephone in the past 6 
weeks.
PROMIS Pediatric Asthma Study uses a prospective design (Figure 1) to identify the 
changes of asthma control status and the corresponding changes of HRQOL in 15 months. 
Asthma control status was reported weekly (26 weeks in total) by parents through the 
research website: weeks 1–13 in the first year (09/2010–05/2011) and weeks 14–26 in the 
second year (09/2011–05/2012). This study only analyzed asthma control status reported at 
baseline of the first year (T1), the first change of asthma control during weeks 2–13 (T2) as 
compared to T1, baseline of the second year (T3), and the first change of asthma control 
during weeks 15–26 (T4) as compared to T3. Pediatric HRQOL was reported through 
telephone interviews with the participating children at 4 time points of assessment once the 
first change of asthma control status was occurred: the first year baseline (T1) and follow-up 
(T2), and the second year baseline (T3) and follow-up (T4).
The attrition rate of participation was low, with 7% and 11% at the end of years 1 and 2, 
respectively. The characteristic significantly different among those retained versus dropped 
out was the child’s age (p<0.05). Children who were retained at T4 were slightly younger 
than those who dropped out at T4 (p=0.03).
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Measures
Parents reported asthma control status for their children using the Asthma Control and 
Communication Instrument (ACCI) (20) that was developed according to the 2007 NAEPP 
EPR-3 (2). The ACCI has demonstrated satisfactory psychometric properties including 
concurrent, discriminant, and clinical known-groups (e.g., forced expiratory volume in 1 
second and peak expiratory flow rate) validity (20). This instrument comprises of 11 items 
covering five domains of asthma outcomes: asthma control (5 items), short-term asthma-
related health care (3 items), direction of asthma symptoms (1 item), adherence to daily 
asthma medication (1 item), and asthma concerns (1 item). The overall asthma control status 
for individuals is determined by the 5 items measuring asthma control. A child was assigned 
to adequate control status if all 5 items were endorsed as mild-intermittent status opposed to 
mild-, moderate-, or severe-persistent status (equivalent to EPR-3 well-controlled); 
otherwise, a child was assigned to poor control status (equivalent to EPR-3 not well-
controlled and very poorly controlled) (2).
Pediatric HRQOL was self-reported by children using the PROMIS Asthma Impact Scale 
which is one of PROMIS Pediatric measures. PROMIS Pediatric measures were created 
using qualitative (e.g., focus group and cognitive debriefing (21, 22)) and quantitative 
methodologies (e.g., item response theory (23)) with good psychometric properties including 
test-retest, construct, convergent-discriminant, and known-groups validity (17, 24–26). The 
domain scores of Asthma Impact Scale were calculated through 8 item scores, and converted 
to a T-score of 50 (a SD of 10) derived from the original calibration sample (27). Higher 
domain scores indicate worse HRQOL.
This study used the parental report to assess asthma control status because some asthma 
control items in the ACCI asked for medication use, occurrence of asthma attack, etc., and 
we believe that parents can provide more accurate information than children. In contrast, 
pediatric HRQOL was assessed through the child self-report which is in consistent with the 
common practice of PROMIS Pediatric measures.
Children’s age, gender, race/ethnicity, comorbidities with other chronic conditions, and 
parental age, marital status, and educational attainment reported by parents at baseline of the 
first year were included in the analyses. Treatment data were not emphasized because we 
focused on the common fluctuation of disease activities (e.g., asthma control) that occurred 
in children to assess the concomitant changes in HRQOL.
Statistical Analyses
T-tests, ANOVA or Χ2 tests were conducted to examine bivariate associations of asthma 
control status with socio-demographic characteristics and HRQOL, respectively, by each 
time point. A linear regression was performed using HRQOL as the dependent variable and 
asthma control as the main independent variable, controlling for participants’ socio-
demographic variables. Two latent growth models (LGMs) were implemented: unconditional 
LGM (Model 1 in Figure 2) for exploring the changes in HRQOL over time and conditional 
LGMs (Models 2 and 3 in Figure 2) for quantifying the longitudinal relationship between 
asthma control and HRQOL by adjusting for socio-demographic factors collected at baseline 
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of the first year. LGM possesses advantages over the traditional models (e.g., generalized 
estimating equations and repeated-measure analysis of covariance (28)), typically 
parameterizing the initial status and rate of change in outcomes over times. Because the 
trend in mean HRQOL scores across time points was linear (Appendix 1), LGMs were 
performed to examine the factors that contributed to linear changes of HRQOL.
Specifically, unconditional LGM (Model 1) was performed to describe the trajectories of 
children’s HRQOL across T1 through T4 by testing the intercept and slope parameters. The 
intercept parameter represents the initial status of HRQOL, and the slope parameter 
indicates the rate of HRQOL change over 4 time points. For model identification purpose, 
the factor loadings for the intercept were fixed to 1, and the factor loadings for the slope 
were assigned based on the time spacing of T2, T3, and, T4 different from T1, respectively. 
For all participants, each time point was centered to baseline of year 1 (T1) (29). After the 
centering, the factor loading of T1 was 0, and the average time spacing was 1.66 months 
between T2 and T1, 11.96 months between T3 and T1, and 13.72 months between T4 and 
T1. Because the variability in measurement occasions between participants was not 
substantial and not expected to affect results (30), we used the average time spacing to 
define an expected growth trajectory.
Two conditional LGMs (Models 2 and 3) were performed to identify factors contributing to 
the changes in HRQOL. The first conditional LGM (Model 2) was performed to test the 
relationships of asthma control status with HRQOL, and the influence of participants’ socio-
demographic factors on the growth of HRQOL. Socio-demographic factors were 
hypothesized to influence the variations in intercept and slope of HRQOL scores. Built on 
Model 2, the second conditional LGM (Model 3) was performed by additionally accounting 
for the effect of socio-demographic factors on asthma control status at each time point.
Comparative fit index (CFI) and the root mean square error of approximation (RMSEA) 
were used to evaluate the adequacy of the model fit for LGMs. CFI ≥ 0.95 and RMSEA ≤ 
0.06 were deemed as satisfactory fits (31, 32). LGMs were performed using Mplus 7.3.2 
(Muthén & Muthén, Los Angeles, CA), and other analyses were performed using SAS 9.4 
(SAS Institute Inc., Cary, NC).
RESULTS
Participant Characteristics (Table 1)
At baseline, the mean age of the children (N=229) was 12.2 years old (SD=2.6); 59% were 
boys; and 38% were non-Hispanic White. For parents, the mean age was 40.6 years old 
(SD=8.7); most had an education of some college, associate degree, or college degree 
(60.2%), and had family income between $15,000 and $35,000 (44.5%).
Bivariate Associations of Asthma Control with HRQOL and Participants’ Characteristics 
(Table 2)
Children with poorly-controlled asthma were 44.5% at T1, 40.3% at T2, 37.4% at T3, and 
41.1% at T4. The mean HRQOL consistently improved from T1 to T4 with scores 48.1 
(SD=10.2) at T1, 46.5 (SD=10.1) at T2, 45.4 (SD=10.1) at T3, and 44.9 (SD=10.2) at T4 
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(p<0.001; Appendix 1). Children with poorly-controlled asthma status had significantly 
worse HRQOL than those with adequate control status across 4 time points (p’s<0.05). 
Parents with educational attainment of high school and below (p<0.05), and children with 
more chronic conditions (p<0.01) had higher rates of poorly-controlled asthma at T1. 
Children who were non-Hispanic Black (p<0.05) and had more chronic conditions (p<0.05) 
were also more likely to have poorly-controlled asthma at T3 than children who were non-
Hispanic White and had fewer chronic conditions.
Multivariable Associations of HRQOL with Asthma Control and Participants’ 
Characteristics (Table 3)
Compared with adequately-controlled asthma status, poorly-controlled status was 
significantly associated with impaired HRQOL with score differences by 5.25 at T1 
(p<0.001), 6.24 at T2 (p<0.001), 6.68 at T3 (p<0.001), and 3.83 at T4 (p<0.05), respectively, 
after adjusting for participants’ characteristics. Parents with educational attainment of high 
school or below had children with poorer HRQOL at T1 (β=3.47, p<0.05) and T2 (β=3.80, 
p<0.05) compared with parents with educational attainment of college or an advanced 
degree. Boys had better HRQOL than girls at T4 (β=−3.59, p<0.05).
Change of HRQOL based on Latent Growth Model (Table 4)
The unconditional LGM (Model 1) shows an excellent model performance (X2=7.00, df=5, 
p=0.22, CFI=0.99, RMSEA=0.04). For the HRQOL trajectory, the mean intercept was 47.8 
(p<0.001), and the variance of the intercepts was 69.32 (p<0.001), suggesting different 
HRQOL at the baseline among individuals. The mean slope was −0.19 (p<0.01), suggesting 
a significant improvement in HRQOL from T1 to T4. The variance of the slopes was 0.29 
(p<0.001), indicating the rates of increase in HRQOL among individuals varied 
significantly. Correlation between the intercept and slope parameters was −0.41 (p<0.001), 
implying that individuals with higher HRQOL at baseline tended to have slower rates of 
changes over time.
The conditional LGMs (Models 2 and 3) were performed by adding asthma control as a 
time-varying predictor and participants’ year 1 baseline socio-demographic characteristics 
into the unconditional LGM. This model reveals an excellent model performance (X2=83.71, 
df=69, p=0.11, CFI=0.95, RMSEA=0.03). The mean intercept for Model 2 was 41.31 
(p<0.001) and the variance of the intercepts was 57.75 (p<0.001), suggesting that children 
possessed different levels of HRQOL at the beginning after adjusting for asthma control 
status and socio-demographic characteristics. Model 3 (Figure 2) revealed an excellent 
model performance (X2=37.35, df=33, p=0.28; CFI=0.98; RMSEA=0.03).
Longitudinal Associations between Asthma Control and HRQOL based on Latent Growth 
Model (Table 5)
Model 2 shows that poor asthma control status was a significant predictor of impaired 
HRQOL across different time points, with significant β coefficients ranging from 0.18 to 
0.31 (p’s<0.001), except for the coefficient of asthma control status at T1 related to HRQOL 
at T2 (p>0.05). Parents with education of high school or below had children with worse 
initial HRQOL at baseline of year 1 (β=0.51, p<0.01) than those with a college education or 
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above. For the rate of HRQOL change, since higher scores represent worse HRQOL, 
negative coefficients on the slopes indicate improving HRQOL. Therefore, boys and 
Hispanic children reported increasing HRQOL over time compared with girls (β=−0.43, 
p<0.05) and non-Hispanic White (β=−0.64, p<0.01), respectively.
Model 3 shows that the effects of poor asthma control on HRQOL impairment across 4 time 
points were all statistically significant (βs ranged from 0.35 to 0.51; p’s<0.001), except for 
the effects of asthma control at T1 on HRQOL at T2 (β=0.16, p>0.05). Parents with an 
education of high school or below reported worse initial HRQOL at baseline of year 1 than 
those with a college education or above (β=0.39, p<0.05). Hispanic children had increasing 
HRQOL over time compared with non-Hispanic White (β=−0.75, p<0.01).
DISCUSSION
This study examined the associations between asthma control status and asthma-specific 
HRQOL in children from low-income families using longitudinal data and LGM 
methodology. Instead of evaluating treatment effects on asthma outcomes, this study 
quantified the natural changes of HRQOL among children who received usual care during 
the changes of asthma control. Because asthma control status was reported prior to HRQOL, 
our results revealed a temporal relationship between the changes of asthma control status 
and the consequent variations in HRQOL. This study is among the first attempts to 
investigate the longitudinal relationship of asthma control status with HRQOL in children 
with significant baseline covariates.
We found an improvement in HRQOL during the study period; however, the magnitude of 
improvement decreased when asthma control status and participants’ characteristics were 
taken into consideration. Parental education was related to variations in the initial HRQOL 
and children’s race/ethnicity was associated with different rates of change in HRQOL. 
Although the change in HRQOL can be explained by the change of asthma control status 
and participants’ baseline characteristics, the improvement in HRQOL might also be 
attributed by regression to the mean in which children tended to report higher HRQOL over 
time due to their familiarity with the survey (19); or the Hawthorne effect. Our recent 
publication further reveals that response shift pheromone (i.e., changing the internal standard 
to interpret the meaning of PROMIS items when study subjects growth within a 1.5-year 
period) was minimal (33). Thus, we believe that the child’s age is less likely to influence the 
change of HRQOL during the study period. Nevertheless, our finding is consistent with the 
previous non-interventional study showing improved HRQOL over the observational period 
(7).
The significant beta coefficients for the effect of asthma control on HRQOL ranged from 
0.18 to 0.51, suggesting that 1 unit change in asthma control was associated with 0.18 to 
0.51 unit change in HRQOL on a 1SD metric. Our previous PROMIS study found that MIDs 
determined by children, caregivers, and pediatricians for the PROMIS Pediatric measures 
ranged from 0.2 to 0.3 on 1SD metric (34). Therefore, HRQOL changes related to asthma 
control changes are clinically meaningful.
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Our findings have important clinical implications for managing outcomes of asthmatic 
children. Given that the changes in pediatric HRQOL are significantly driven by asthma 
control status, it is crucial to design innovative approaches to assess children’s asthma 
control and provide individualized therapy to maintain asthma in well-controlled status. 
Implementing effective and efficient monitoring systems in both clinical and community 
settings are the key to assist asthmatic children, their parents, and clinicians to monitor 
asthma symptoms, to identify poorly-controlled asthma status, and to adjust medication. 
Rapid learning approaches, as an example, have been successfully used in people with 
chronic conditions (e.g., chronic pulmonary diseases (35) and cancer survivors (36)) to assist 
clinicians to receive decision supports, to provide timely treatment regimens, and to improve 
long-term HRQOL through greater confidence in self-care. Future studies may apply the 
rapid learning approach to design asthma control monitoring systems for asthmatic children 
to improve HRQOL.
We found that parental education was related to variations in the initial HRQOL and 
children’s race/ethnicity was associated with the change of HRQOL. This is because 
individuals of different cultures, education, ethnicities possess varied beliefs and perceptions 
toward managing asthma disease (37–39). Our finding echoes the broader literature showing 
that cultural background, language proficiency, health literacy, and health beliefs are inter-
related and collectively influence healthcare utilization and HRQOL in asthmatic 
populations (40, 41). Specifically, Hispanics with low health literacy are likely to have 
insufficient health knowledge about the causes of asthma and inappropriate use of asthma 
medication, leading to poor disease progression (37). Interestingly, our study found that 
Hispanic children reported a negative rate of change in HRQOL over time compared with 
non-Hispanic White children after taking asthma control status into consideration (Model 2: 
β= −0.64, p<0.01; Model 3: β= −0.75, p<0.01). The negative rate of changes represents the 
increase of HRQOL during the observational period and implies that appropriate 
interventions targeted at asthma control status for Hispanic children may lead to more 
promising results than non-Hispanic White children. In this regard, clinical practice should 
implement literacy- and culture-tailored approaches to monitor and improve outcomes for 
children with asthma; for example, using community health workers received specific 
training to manage individuals who have literacy/education and culture/ethnic-sensitive 
demand (42, 43).
This study has several limitations. First, asthmatic children were selected from economically 
disadvantaged families. Therefore, the findings may not be generalizable to the general 
population. Second, we collected asthma control status through parental reports but HRQOL 
through the child’s self-reports. As described in the Methods section, a parent-report was 
used because several items in the ACCI assess medication use and parents often have better 
knowledge of the types and dosages of asthma medicine than do children. Evidence shows 
that both parents and children are likely to over-report adherence to medication compared 
with the use of objective assessments (e.g., electronic canister measures) (44). However, 
medication use reported by parents and children was not significantly different (44). Because 
differences in asthma control status between parent proxy-reports and child self-reports are 
under studied, further research should compare validity of asthma control data collected 
from proxy-reports and self-reports for increasing the precision of asthma control measures. 
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For HRQOL, evidence suggests that differences in pediatric HRQOL rated by parents and 
children are smaller in physical domains than in psychosocial domains (45–47). We have 
previously emphasized the importance of collecting dyadic ratings of pediatric HRQOL for 
clinical decision-making, especially among children with severe chronic conditions (47). 
However, it is not feasible to collect a dyadic report of pediatric HRQOL in this asthma 
study because data collection processes at each time point is very time consuming 
(approximately 30 to 35 minutes to complete by the parent and child, respectively). We 
believe that the use of advanced technology (e.g., computerized adaptive tests; CATs) to 
decrease response burden can facilitate the collection of dyadic data for pediatric HRQOL 
assessment. Third, we examined the longitudinal associations of asthma control changes 
with HRQOL changes after controlling for socio-demographic factors. However, the 
longitudinal associations may be confounded by coping skills and environmental stressors 
(e.g., air pollution) which were not included in this study. Last, we did not collect 
information of written action plans or other standards of care from individual participants 
which may confound the association of asthma control status with HRQOL. Our sample was 
recruited from Florida Medicaid and the Children’s Health Insurance Program itself, and the 
children enrolled attend multiple practices across the state of Florida. All participants are 
able to access primary care physicians or pediatricians (i.e., usual source of care) which may 
and should offer routine asthma care; therefore, we believe the variation of asthma care in 
our study sample is small. Additionally, a previous study found that if the action plan is 
offered, physicians discuss the action plans with parents and children who enroll in public 
insurance programs more often than those in other insurance programs (48). Unfortunately, 
we did not collect data of written action plans or standards of care from participants, and the 
extent to which these treatment factors impact the association of asthma control with 
HRQOL is warranted in further studies.
In conclusion, while HRQOL changed over time in publicly insured children, these changes 
were explained by asthma control status and vulnerable socio-demographic factors. It is 
important to design appropriate interventions to improve asthma control status that could 
lead to optimal HRQOL for minority children and potentially result in a reduction of health 
disparities.
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Figure 1. 
Study design to identify the changes of asthma control status
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Figure 2. 
Unconditional (Model 1) and conditional (Models 2 and 3) latent growth analytic scheme
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Table 1
Characteristics of study participants at baseline of the first year (N=229)
Number of subject (%) or mean (SD)
Child’s age in years 12.2 (2.6)
Child’s gender, %
Boy 135 (58.9 %)
Girl 94 (41.1%)
Child’s race/ethnicity, %
White/non-Hispanic 87 (38.0%)
Black/non-Hispanic 59 (25.8%)
Hispanic 63 (27.5%)
Other 20 (8.7%)
Parental age in years 40.6 (8.7)
Parental race/ethnicity, %
White/non-Hispanic 97 (42.4%)
Black/non-Hispanic 60 (26.2%)
Hispanic 59 (25.8%)
Other 13 (5.7%)
Parental education background, %
High school or below 74 (32.7%)
Some college, associate, and
college degree
136 (60.2%)
Advanced degree 16 (7.1%)
Family income,%
< $14,999 47 (20.5%)
$15,000– $34,999 102 (44.5%)
$35,000 –$54,999 57 (24.9%)
>55,000 23 (10.0%)
Parental marital status,%
Never married 40 (17.5%)
Married 118 (51.5%)
Living with partner in committed
relations
10 (4.4%)
Separated 9 (3.9%)
Divorced 45 (19.7%)
Widowed 7 (3.1%)
Child’s number of chronic conditions 1.5 (0.8)
Abbreviation: SD, standard deviation.
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